Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents.

children and adolescents papillary thyroid carcinoma recurrence thyroglobulin antibody thyroid peroxidase antibody

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 25 02 2022
accepted: 04 05 2022
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Numerous studies reported connection between papillary thyroid carcinoma (PTC) and thyroid autoantibody in adults, but few of them have investigated whether there is a similar link in children and adolescents. The purpose of this research was to explore the relationship between clinicopathological features, prognosis and preoperative thyroid peroxidase antibody (TPOAb) as well as thyroglobulin antibody (TgAb) status in children and adolescents with PTC. This study retrospectively reviewed 179 patients of PTC who underwent a thyroidectomy from January 2000 to June 2021 at Tianjin Medical University Cancer Hospital. We compared preoperative TgAb and TPOAb status with the clinicopathological features and prognosis of children and adolescents with PTC in different age groups. Patients with positive preoperative TPOAb and TgAb had lower recurrence rate in the younger group ( Our study found that presence of preoperative TPOAb and TgAb could serve as novel prognostic factors for predicting recurrence of PTC in children.

Sections du résumé

Background UNASSIGNED
Numerous studies reported connection between papillary thyroid carcinoma (PTC) and thyroid autoantibody in adults, but few of them have investigated whether there is a similar link in children and adolescents. The purpose of this research was to explore the relationship between clinicopathological features, prognosis and preoperative thyroid peroxidase antibody (TPOAb) as well as thyroglobulin antibody (TgAb) status in children and adolescents with PTC.
Methods UNASSIGNED
This study retrospectively reviewed 179 patients of PTC who underwent a thyroidectomy from January 2000 to June 2021 at Tianjin Medical University Cancer Hospital. We compared preoperative TgAb and TPOAb status with the clinicopathological features and prognosis of children and adolescents with PTC in different age groups.
Results UNASSIGNED
Patients with positive preoperative TPOAb and TgAb had lower recurrence rate in the younger group (
Conclusions UNASSIGNED
Our study found that presence of preoperative TPOAb and TgAb could serve as novel prognostic factors for predicting recurrence of PTC in children.

Identifiants

pubmed: 35756669
doi: 10.3389/fonc.2022.883591
pmc: PMC9213685
doi:

Types de publication

Journal Article

Langues

eng

Pagination

883591

Informations de copyright

Copyright © 2022 Huang, Zhi, Zhang, Qin, Zhao, Zheng and Gao.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Thyroid. 2014 Jul;24(7):1139-45
pubmed: 24702238
World J Surg. 2020 Feb;44(2):363-370
pubmed: 31502005
J Surg Res. 2020 May;249:58-66
pubmed: 31923715
Thyroid. 2015 Jul;25(7):716-59
pubmed: 25900731
Thyroid. 2014 Mar;24(3):488-93
pubmed: 23971786
Endocrinol Metab Clin North Am. 2005 Sep;34(3):725-44, x
pubmed: 16085168
Thyroid. 2014 Jan;24(1):35-42
pubmed: 23731273
Clin Endocrinol (Oxf). 2021 Oct;95(4):649-656
pubmed: 33914928
Front Endocrinol (Lausanne). 2020 Jul 15;11:452
pubmed: 32760349
Front Oncol. 2022 Feb 24;12:833775
pubmed: 35280803
Endocrine. 2017 Mar;55(3):954-958
pubmed: 27878772
Endocr Relat Cancer. 2017 Sep;24(9):485-493
pubmed: 28696209
Eur J Endocrinol. 2015 Dec;173(6):827-33
pubmed: 26369577
Korean J Intern Med. 2018 Nov;33(6):1050-1057
pubmed: 30396251
Eur J Endocrinol. 2013 Feb 15;168(3):343-9
pubmed: 23211578
Endocrine. 2017 Oct;58(1):176-183
pubmed: 28884426
J Endocrinol Invest. 2007 Apr;30(4):346-7
pubmed: 17556874
Psychol Health Med. 2020 Aug 20;:1-9
pubmed: 32816557
Ann Surg Oncol. 2010 Oct;17(10):2545-53
pubmed: 20429037
Acta Oncol. 2011 Nov;50(8):1228-34
pubmed: 21871002
Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7778-7787
pubmed: 30536322
Head Neck. 2018 Oct;40(10):2271-2279
pubmed: 29935011
Thyroid. 2020 Apr;30(4):548-556
pubmed: 31910105
Ann Intern Med. 2003 Sep 2;139(5 Pt 1):346-51
pubmed: 12965943
Endocr Pract. 2021 Apr;27(4):306-311
pubmed: 33645517
Int J Cancer. 2019 Mar 15;144(6):1414-1420
pubmed: 30357831
Thyroid. 2018 Aug;28(8):997-1003
pubmed: 29845894
Arq Bras Endocrinol Metabol. 2013 Apr;57(3):193-204
pubmed: 23681265
Ann Hematol. 2002 Nov;81(11):641-5
pubmed: 12454702
Clin Endocrinol (Oxf). 2018 Jul;89(1):100-109
pubmed: 29672893
AMA Arch Surg. 1955 Feb;70(2):291-7
pubmed: 13227748
Clin Endocrinol (Oxf). 2018 Jan;88(1):123-128
pubmed: 28906015
Psicothema. 2018 May;30(2):201-206
pubmed: 29694322
Oral Oncol. 2019 Apr;91:29-34
pubmed: 30926059
Thyroid. 2014 Jul;24(7):1107-14
pubmed: 24708347
Gland Surg. 2019 Oct;8(5):507-515
pubmed: 31741881
World J Surg. 2012 Jun;36(6):1274-8
pubmed: 22270990
Endocr Rev. 1994 Dec;15(6):788-830
pubmed: 7705281
Clin Endocrinol (Oxf). 2017 Sep;87(3):292-299
pubmed: 28493284
Thyroid. 2017 Jun;27(6):751-756
pubmed: 28463585
J Endocrinol Invest. 2013 May;36(5):313-20
pubmed: 22931861
Endocr J. 2013;60(7):871-6
pubmed: 23585494
J Clin Endocrinol Metab. 2001 Mar;86(3):1346-54
pubmed: 11238531

Auteurs

Dongmei Huang (D)

Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Jingtai Zhi (J)

Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Jinming Zhang (J)

Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Xuan Qin (X)

Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Jingzhu Zhao (J)

Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Xiangqian Zheng (X)

Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Ming Gao (M)

Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Department of Thyroid and Breast Surgery, Tianjin Union Medical Center, Tianjin, China.
Tianjin Key Laboratory of General Surgery Inconstruction, Tianjin Union Medical Center, Tianjin, China.

Classifications MeSH